Willner & Heller’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Sell |
7,550
-864
| -10% | -$160K | 1.18% | 20 |
|
2025
Q1 | $1.76M | Sell |
8,414
-34
| -0.4% | -$7.12K | 1.63% | 11 |
|
2024
Q4 | $1.5M | Buy |
8,448
+491
| +6% | +$87.2K | 1.32% | 14 |
|
2024
Q3 | $1.57M | Sell |
7,957
-25
| -0.3% | -$4.94K | 1.4% | 12 |
|
2024
Q2 | $1.37M | Buy |
7,982
+77
| +1% | +$13.2K | 1.31% | 14 |
|
2024
Q1 | $1.44M | Sell |
7,905
-57
| -0.7% | -$10.4K | 1.43% | 12 |
|
2023
Q4 | $1.23M | Buy |
+7,962
| New | +$1.23M | 1.38% | 13 |
|
2022
Q4 | $1.21M | Sell |
7,465
-119
| -2% | -$19.2K | 1.71% | 8 |
|
2022
Q3 | $1.02M | Buy |
7,584
+275
| +4% | +$36.9K | 1.64% | 10 |
|
2022
Q2 | $1.12M | Sell |
7,309
-180
| -2% | -$27.6K | 1.74% | 8 |
|
2022
Q1 | $1.01M | Buy |
7,489
+82
| +1% | +$11.1K | 1.25% | 16 |
|
2021
Q4 | $799K | Buy |
+7,407
| New | +$799K | 1.06% | 21 |
|